Skip to main content
FinSpry Logo
FinSpry
RXRX logo
RXRX
(NASDAQ)
Recursion Pharmaceuticals, Inc.
$2.96-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Recursion Pharmaceuticals (RXRX) Stock Price & Financial Analysis

Recursion Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.82 - $2.95
52-Week High$7.18
52-Week Low$2.80
Open$2.92
Volume19.04M
Average Volume (3M)12.63M
Market Cap1.50B
Shares Outstanding526.72M
Price to Sales (P/S)20.19
Price to Book (P/B)1.33
EV/EBITDA-1.52
Revenue (TTM)74.37M
Net Income (TTM)-644.76M
Free Cash Flow (TTM)-378.28M
EPS (TTM)$-1.44
Profit Margin-866.98%
Operating Margin-871.51%
Return on Equity (ROE)-57.01%
Debt to Equity0.07
50-Day MA$3.37
200-Day MA$4.43
52-Week Change-29.74%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Recursion Pharmaceuticals

What is the current stock price for RXRX?

As of the latest trading session, RXRX stock trades at $2.89. The 52-week range is $2.80–$7.18, with a day range of $2.82–$2.95.

What is the P/E ratio for RXRX?

The P/E ratio (Price-to-Earnings) for RXRX is shown in the Key Statistics section. This valuation metric helps compare Recursion Pharmaceuticals, Inc. to industry peers.

Does RXRX pay dividends?

Recursion Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RXRX?

Based on 2 analysts, the consensus for RXRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of RXRX?

Recursion Pharmaceuticals's market capitalization is $1.52B, classifying it as a small-cap company. Recursion Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.